A Study to Evaluate YH001 in Combination With Toripalimab in Subjects With Advanced NSCLC and HCC (Q113924799)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
A Study to Evaluate YH001 in Combination With Toripalimab in Subjects With Advanced NSCLC and HCC
clinical trial

    Statements

    YH001 (English)
    0 references
    An Open-Label, Non-Randomized, Multi-center Phase 2 Study of YH001 in Combination With Toripalimab in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC) and Hepatocellular Carcinoma (HCC) (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    December 2022
    0 references
    December 2022
    0 references
    80
    0 references
    18 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit